跳至主要内容
临床试验/JPRN-UMIN000033693
JPRN-UMIN000033693已完成未知

A retrospective cohort study to investigate the incidence of cachexia in gastric cancer patients - A retrospective cohort study to investigate the incidence of cachexia in gastric cancer patients

ONO PHARMACEUTICAL CO., LTD.0 个研究点目标入组 131 人开始时间: 2018年8月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
131

研究概览

简要总结

Incidence of WL was 53% at the first 12 weeks after starting first-line chemotherapy, and increased to 88% after 48 weeks. Overall survival rates were significantly associated with WL at 12, 24, and 48 weeks. Appetite loss and fatigue were more frequent and more severe in patients with WL.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who meet at least one of the following exclusion criteria are not included. 1) Patients who underwent surgical operation of the gastrointestinal tract within the last 6 months excluding stent placement in the gastrointestinal tract or gastroduodenostomy 2) Patients with weight loss distinctly caused by a gastrointestinal transit disorder 3) Patients with simultaneously active, double cancer (Stage I intraepithelial carcinoma, intramucosal carcinoma, superficial bladder carcinoma, or other cancers without recurrence for 5 years or more can be registered) 4) Patients with missing of weight data over 12 weeks at the time of visit and during the subsequent medical consultation period 5) Patients who underwent puncture for ascitic fluid at the beginning of initial systemic chemotherapy

研究者

发起方
ONO PHARMACEUTICAL CO., LTD.

相似试验